7 patents
Utility
ANTI-CD40 Antibodies and Methods of Use
17 Feb 22
The present invention provides high affinity anti-CD40 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of cancer and other diseases.
Yongke ZHANG, Guo-Liang YU, Weimin ZHU
Filed: 7 Apr 21
Utility
ANTI-CD40 Antibodies and Methods of Use
17 Feb 22
The present invention provides high affinity anti-CD40 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of cancer and other diseases.
Yongke ZHANG, Guo-Liang YU, Weimin ZHU
Filed: 15 Apr 21
Utility
Anti-PD-L1 antibodies and methods of use
3 Aug 21
Provided are anti-programmed death-ligand 1 (PD-L1) monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of inflammatory and oncological diseases.
Pia Björck, Christine Tan, Erin Filbert, Xiaodong Yang
Filed: 17 Jan 19
Utility
Anti-vista Antibodies and Methods of Use
13 May 21
Provided are anti-VISTA monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of a variety of inflammatory, oncological, and infectious diseases.
Erin L. Filbert, Christine TAN, Pia BJÖRCK, Xiaodong YANG
Filed: 22 Jun 18
Utility
ANTI-CD40 Antibodies In Combination and Methods of Use
13 May 21
The present invention provides methods that utilize an agonistic anti-CD40 antibody in combination with another immune modulating agent, such as an immune checkpoint inhibitor (e.g., PD-1 inhibitor, PD-L1 inhibitor, CTLA-4 inhibitor, or VISTA inhibitor) and/or an innate immunity activator (e.g., TLR-4 agonist) and related compositions.
Pia Björck, Erin L. Filbert, Xiaodong Yang
Filed: 23 Jun 20
Utility
Anti-CD40 antibodies
11 May 21
The present invention provides high affinity anti-CD40 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of cancer and other diseases.
Yongke Zhang, Guo-Liang Yu, Weimin Zhu
Filed: 19 Dec 16
Utility
Anti-rankl Antibodies and Methods of Use
9 Oct 19
The present invention provides anti-RANKL monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of rheumatoid arthritis and other diseases.
Yongke Zhang, Xiaodong Yang, Guo-Liang Yu, Weimin Zhu
Filed: 26 Feb 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first